Verity Asset Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,361
Closed -$219K 113
2014
Q4
$219K Buy
+2,361
New +$219K 0.21% 67